At a minimum, successful cochlear implantation requires that electrical impulses be delivered to a surviving spiral ganglion cell population, and that these impulses be transmitted to a functioning auditory cortex…
Since the first cochlear implant approved by the US Food and Drug Administration in the early 1980s, great advances have occurred in cochlear implant technology. With these advances, patient selection,…
This article provides an overview of the technical considerations of endoscopy of the posterolateral skull base and cerebellopontine angle (CPA). Specific areas of focus are on the instrumentation requirements for…
Information on the genetic basis of and testing for disorders with hearing loss is increasing rapidly. In this review, the authors explain genetic terminology, the principles of inheritance, and the…
J. Thomas Roland Jr, MD, Guest Editor David S. Haynes, MD, Guest Editor
Facial nerve dysfunction after resection of a vestibular schwannoma is one of the most common indications for facial nerve habilitation. This article presents an overview of common and emerging management…
Although unilateral hearing loss is often the initial sign of vestibular schwannoma (VS), the pathogenesis of the associated structures within the cerebellopontine angle can result in vestibular, facial, or vascular…
Vestibular schwannomas (VS) are among the most common benign tumors of the central nervous system. Bilateral VS are the hallmark of neurofibromatosis type II, commonly leading to complete deafness and…
Local support groups are an important part of the support network for acoustic neuroma and neurofibromatosis patients. For many people, the local support group is the only place where they…
Acoustic neuromas (ANs) are the most common tumors of the cerebellopontine angle. Although numerous advances have occurred in the operative management of AN and perioperative care leading to a significant…
